ERS International Congress 2023: highlights from the Thoracic Oncology Assembly
- PMID: 38410708
- PMCID: PMC10895436
- DOI: 10.1183/23120541.00860-2023
ERS International Congress 2023: highlights from the Thoracic Oncology Assembly
Abstract
Lung cancer is the leading cause of cancer mortality in the world. It greatly affects the patients' quality of life, and is thus a challenge for the daily practice in respiratory medicine. Advances in the genetic knowledge of thoracic tumours' mutational landscape, and the development of targeted therapies and immune checkpoint inhibitors, have led to a paradigm shift in the treatment of lung cancer and pleural mesothelioma. During the 2023 European Respiratory Society Congress in Milan, Italy, experts from all over the world presented their high-quality research and reviewed best clinical practices. Lung cancer screening, management of early stages of lung cancer, application of artificial intelligence and biomarkers were discussed and they will be summarised here.
Copyright ©The authors 2024.
Conflict of interest statement
Conflict of interest: The authors have nothing to disclose.
Similar articles
-
ERS International Congress 2022: highlights from the Thoracic Oncology Assembly.ERJ Open Res. 2023 Aug 14;9(4):00579-2022. doi: 10.1183/23120541.00579-2022. eCollection 2023 Jul. ERJ Open Res. 2023. PMID: 37583965 Free PMC article.
-
ERS International Congress 2021: highlights from the Thoracic Surgery and Lung Transplantation Assembly.ERJ Open Res. 2022 May 23;8(2):00649-2021. doi: 10.1183/23120541.00649-2021. eCollection 2022 Apr. ERJ Open Res. 2022. PMID: 35615414 Free PMC article.
-
ERS International Congress 2023: highlights from the Paediatrics Assembly.ERJ Open Res. 2024 Feb 26;10(1):00853-2023. doi: 10.1183/23120541.00853-2023. eCollection 2024 Jan. ERJ Open Res. 2024. PMID: 38410713 Free PMC article.
-
Highlights of thoracic oncology from the 2018 ERS International Congress.ERJ Open Res. 2019 Jun 17;5(2):00222-2018. doi: 10.1183/23120541.00222-2018. eCollection 2019 Apr. ERJ Open Res. 2019. PMID: 31218220 Free PMC article. Review.
-
ERS International Congress 2022: highlights from the Thoracic Surgery and Lung Transplantation Assembly.ERJ Open Res. 2023 Apr 17;9(2):00671-2022. doi: 10.1183/23120541.00671-2022. eCollection 2023 Mar. ERJ Open Res. 2023. PMID: 37077552 Free PMC article. Review.
Cited by
-
ERS International Congress 2023: highlights from the Respiratory Clinical Care and Physiology Assembly.ERJ Open Res. 2024 May 20;10(3):00178-2024. doi: 10.1183/23120541.00178-2024. eCollection 2024 May. ERJ Open Res. 2024. PMID: 38770003 Free PMC article.
References
-
- European Commission . European Health Union: Commission welcomes adoption of new EU cancer screening recommendations. Date last updated: 9 December 2022. https://ec.europa.eu/commission/presscorner/detail/en/ip_22_7548
-
- Leleu O, Storme N, Basille D, et al. . Lung cancer screening by low-dose CT scan in France: final results of the DEP'K80 study after three rounds. Eur Respir J 2023; 62: Suppl. 67, OA3264. - PubMed
-
- Blum TG. The pioneering Strengthening the screening of Lung Cancer in Europe (SOLACE) project has now been launched. www.ersnet.org/news-and-features/news/solace-project-launch/
Grants and funding
LinkOut - more resources
Full Text Sources